PanAgora Asset Management »

Xenon Pharmaceuticals shares owned by PanAgora Asset Management

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by PanAgora Asset Management from 13F filings

Historical chart of PanAgora Asset Management investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by PanAgora Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by PanAgora Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $40M 664k 60.36

More positions owned by PanAgora Asset Management

Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Inc-cl A Common (GOOGL)
Amazon.com Common (AMZN)
Broadcom Common (AVGO)
Alphabet Inc-cl C Common (GOOG)
Micron Technology Common (MU)
Advanced Micro Devices Common (AMD)
Meta Platforms Inc-class A Common (META)
Eli Lilly & Co Common (LLY)
Tesla Common (TSLA)
Lam Research Corp Common (LRCX)
General Electric Common (GE)
Bank Of America Corp Common (BAC)

View all positions for PanAgora Asset Management

Top funds holding Xenon Pharmaceuticals

FMR
BlackRock
venBio Select Advisor
Polar Capital Holdings
Driehaus Capital Management
Jupiter Topco
Henderson Group
Jpmorgan Chase & Co
Capital Research and Management Company - Division 3
State Street Corporation
Two Sigma Investments
Deerfield Management Company
Affinity Asset Advisors
Alliancebernstein
Westfield Capital Management Company

View all funds holding Xenon Pharmaceuticals